Development and partial validation of a mouse model for predicting drug hypersensitivity reactions

Area of Science:

• Immunotoxicology
• Preclinical drug safety assessment

Background:

• Existing animal models for predicting drug allergenicity require further optimization and validation.
• The mouse lymph node proliferation assay (LNPA) showed initial promise but lacked subsequent investigation.

Purpose of the Study:

• To optimize and validate the LNPA using positive and negative control drugs.
• To determine the sensitivity, specificity, and predictive value of the LNPA with a non-radioactive endpoint.

Main Methods:

• Mice were subcutaneously injected with drugs or vehicle for three days.
• Draining lymph nodes were harvested on Day 6, and cell numbers were quantified via flow cytometry.
• A stimulation index was calculated to classify 'responders' based on cell counts relative to vehicle controls.

Main Results:

• The LNPA demonstrated a sensitivity of 75% and a specificity of 74% with 12 positive and six negative control drugs.
• The model achieved a Receiver Operating Characteristic AUC of 0.80, indicating good predictive value.
• A stimulation index threshold of ≥2.5-fold the vehicle mean was established for classifying responders.

Conclusions:

• The optimized LNPA is a potentially valuable tool for identifying drug candidates with allergic potential.
• Further research into the mechanisms of lymph node response could enhance the assay's sensitivity and specificity.